Human plasma-derived eNAMPT-containing extracellular vesicles promote NAD<sup>+</sup> biosynthesis and thermogenesis in mice. [PDF]
Yoshioka K +6 more
europepmc +1 more source
Targeting TRAF3IP2 disrupts cellular energetics through inhibition of NAMPT in triple negative breast cancer. [PDF]
Willingham K +7 more
europepmc +1 more source
Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models. [PDF]
Kashiwagi E +12 more
europepmc +1 more source
Inhibition of TRAF3IP2 Modulates NAMPT and NAD Metabolism in Glioblastoma. [PDF]
Willingham K +8 more
europepmc +1 more source
A metabolic cell death program downstream of SARM1 couples NAD<sup>+</sup> depletion to BAX activation and APAF1 degradation. [PDF]
Pan W, Guo D, Liu D, Wang X.
europepmc +1 more source
Deficiency of SARM1 attenuates neuronal injury and improves neurological performance in a photothrombotic stroke model. [PDF]
Huang Y +5 more
europepmc +1 more source
Simultaneous Detection and Quantification of Adenine Nucleotides in Mammalian Cultured Cells by HPLC. [PDF]
Kopel B +7 more
europepmc +1 more source
Computational Identification of New Dual PAK4 and NAMPT Inhibitors. [PDF]
Wang Y, Minden A.
europepmc +1 more source
NAMPT Deficiency Promotes Endothelial-Mesenchymal Transition by Inhibiting Energy Metabolism and Lysosomal Acidification in Late-Onset Fuchs Endothelial Corneal Dystrophy. [PDF]
Xie L +10 more
europepmc +1 more source
Beyond cell cycle control: <i>CDKN2A</i> loss is associated with altered NAD<sup>+</sup> metabolic states and increased sensitivity to NAMPT inhibition in glioblastoma. [PDF]
Dubey S +7 more
europepmc +1 more source

